Bioadaptives, Inc.

0.0348+0.00 (+3.42%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · BDPT · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
345.71K
P/E (TTM)
-
Basic EPS (TTM)
-0.03
Dividend Yield
0%

Recent Filings

About

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.

CEO
Mr. James E. Keener
IPO
6/1/2016
Employees
1
Sector
Consumer Defensive
Industry
Packaged Foods